Federal Register / Vol. 74, No. 184 / Thursday, September 24, 2009 / Notices 48747 

FOR FURTHER INFORMATION CONTACT: 

Jeritta Parnell, Contract Policy Division, 

GSA (202) 501–4082 or e-mail 

jeritta.parnell@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

Value engineering is the technique by 

which contractors (1) voluntarily 

suggest methods for performing more 

economically and share in any resulting 

savings or (2) are required to establish 

a program to identify and submit to the 

Government methods for performing 

more economically. These 

recommendations are submitted to the 

Government as value engineering 

change proposals (VECP’s) and they 

must include specific information. This 

information is needed to enable the 

Government to evaluate the VECP and, 

if accepted, to arrange for an equitable 

sharing plan. 

B. Annual Reporting Burden 

Respondents: 400. 

Responses per Respondent: 4. 

Annual Responses: 1,600. 

Hours per Response: 30. 

Total Burden Hours: 48,000. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat (VPR), 1800 F 

Street, NW., Room 4041, Washington, 

DC 20405, telephone (202) 501–4755. 

Please cite OMB Control No. 9000–0027, 

Value Engineering Requirements, in all 

correspondence. 

Dated: September 17, 2009. 

Al Matera, 

Director, Acquisition Policy Division. 

[FR Doc. E9–23089 Filed 9–23–09; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Scientific Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

and the Assistant Secretary for Health 

have taken final action in the following 

case: 

Nagendra S. Ningaraj, PhD, 

Vanderbilt University School of 

Medicine: Based on the reports of an 

investigation conducted by Vanderbilt 

University School of Medicine (VUSM) 

and additional analysis by the Division 

of Investigative Oversight (DIO), ORI, in 

its oversight review, found that 

Nagendra S. Ningaraj, PhD, former 

Associate Professor of Neurological 

Surgery and Cancer Biology, VUSM, 

engaged in scientific misconduct by 

falsifying MALDI–MS images and mass 

spectral tracings and associated text in 

Figure 21 reported in National Cancer 

Institute (NCI), National Institutes of 

Health (NIH), grant application 1 U54 

CA119421–01 and by falsifying MALDI– 

MS images in a presentation during the 

American Association for Cancer 

Research (AACR) meeting held on April 

16–20, 2005, which cited support from 

NCI, NIH, grants R25 CA92943 and P50 

CA098131. 

Specifically, ORI found that: 

1. Respondent reversed the images for 

the control and minoxidil-treated brains 

in Figure 21 of the 1 U54 CA119421–01 

grant application, claiming that 

minoxidil increased delivery of Gleevec 

to the tumor. Respondent also reversed 

the same images in a presentation 

during the AACR meeting in April 2005. 

2. In Figure 21 of the 1 U54 

CA119421–01 grant application, 

Respondent reported mass spectral 

tracings as having been obtained from 

brain tumors in Gleevec-treated mice 

that had been pretreated with minoxidil, 

while in fact they were pretreated with 

another potassium channel opener, 

NS1619, and Respondent falsely stated 

the minoxidil pretreatment caused an 

8-fold increase in Gleevec delivery to 

brain tumors (compared to nonminoxidil pretreated tumors). 

3. Respondent further falsified Figure 

21 of the 1 U54 CA119421–01 grant 

application by juxtaposing the reversed 

MALDI–MS images (obtained with 

mioxidil) with the mass spectral 

tracings (obtained with NS1619) in the 

same figure and by failing to report that 

the images and spectra in the figure 

were actually obtained in totally 

different experiments, performed on 

different dates and with different K+

agonist pretreatments. 

Dr. Ningaraj has entered into a 

Voluntary Settlement Agreement in 

which he has voluntarily agreed, for a 

period of three (3) years, beginning on 

August 31, 2009: 

(1) To be prohibited from serving in 

any advisory capacity to PHS, including 

but not limited to service on any PHS 

advisory committee, board, and/or peer 

review committee, or as a consultant; 

(2) That any institution that submits 

an application for PHS support for a 

research project on which the 

Respondent’s participation is proposed 

or which uses him in any capacity on 

PHS-supported research or that submits 

a report of PHS-funded research on 

which he is involved must submit a 

plan for supervision of his duties to the 

funding agency for approval no later 

than a month before the scheduled 

funding; the supervisory plan must be 

designed to ensure the scientific 

integrity of his research contribution; a 

copy of the supervisory plan also must 

be submitted to ORI by the institution; 

Respondent agrees that he will not 

participate in any PHS-supported 

research until such a supervisory plan is 

submitted to ORI; and 

(3) Respondent will ensure that any 

institution employing him submits, in 

conjunction with each application for 

PHS funds or any report, manuscript, or 

abstract of PHS-funded research in 

which he is involved, a certification that 

the data provided by him are based on 

actual experiments or are otherwise 

legitimately derived and that the data, 

procedures, and methodology are 

accurately reported in the application or 

report. Respondent must ensure that the 

institution send the certification to ORI. 

The certification shall be submitted no 

later than one month before funding and 

concurrently with any report, 

manuscript, or abstract. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

John Dahlberg, 

Director, Division of Investigative Oversight, 

Office of Research Integrity. 

[FR Doc. E9–23046 Filed 9–23–09; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Submission for 

OMB Review; Comment Request; 

NEXT Generation Health Study 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institute of Child Health and Human 

Development (NICHD), the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on July 17, 2009, 

Volume 74, Number 136, pages 34760– 

34761 and allowed 60 days for public 

comment. Two public comments were 

received. One questioned the value of 


srobinson on DSKHWCL6B1PROD with NOTICES